About Voredos
A small, focused bioinformatics company built around one idea — we should be able to read the data of our bodies.
Mission
Voredos SRL was founded to bridge the gap between large-scale (public) human data and the researchers who need to understand it.
We have worked with dozens of companies setting up their data pipelines, compiling meaningful literature reviews and providing strategic advice for technology and platform design.
Leadership
Fleur Leenen
Computational and molecular biologist, data scientist and statistician with Master's degrees from KU Leuven and Ghent University, and a doctorate in Molecular Biology, Epigenetics and Bioinformatics (University of Trier), with research at the Luxembourg Institute of Health. Focus: epigenomics, transcriptomics and computational immunology, with strong wet-lab background.
Postdoctoral research at the University of Toronto on DNA methylation arrays and RNA-Seq pipelines. Active across biotech in Belgium and the US Bay Area for over a decade — algorithm development for complex biological problems and pipeline set-up for NGS data processing.
Dr. Jean-Philippe Bürckert
Bioinformatician and immunologist with a Diplom in Chemistry (RPTU Kaiserslautern-Landau, with distinction) and a doctorate in Bioinformatics and Computational Biology (University of Trier, summa cum laude). Focus: B-cell immunity, immunoglobulin repertoire sequencing and antibody discovery.
Co-Founder & CTO at Ability Biotherapeutics (Montreal, since 2023) — a biotherapeutics company combining AI-driven antibody discovery with logic-gated multispecifics for cancer and autoimmune disease — and Co-Founder & CTO at Nanolynx Biologics AG (Basel, since 2025), developing next-generation nanobody drug conjugates for solid tumours.
Where we are
Voredos SRL is registered in Ramillies, Belgium. Operationally we work remotely with collaborators across Europe and North America. Our infrastructure is hosted in the EU.